Affinity Asset Advisors »

Oaktree Acquisition Corp Iii shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Oaktree Acquisition Corp Iii (OACCU) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Oaktree Acquisition Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Oaktree Acquisition Corp Iii held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oaktree Acquisition Corp Iii by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.7M 250k 10.64
2025-06-30 $2.7M 250k 10.62
2025-03-31 $2.6M 250k 10.38
2024-12-31 $2.5M 250k 10.15

More positions owned by Affinity Asset Advisors

Insmed Com Par $.01 (INSM)
Verona Pharma Sponsored Ads (VRNA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Merus N V (MRUS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Lexeo Therapeutics (LXEO)

View all positions for Affinity Asset Advisors

Top funds holding Oaktree Acquisition Corp Iii

ADAR1 Capital Management
Affinity Asset Advisors
Athos Capital
Clear Street
UBS Group

View all funds holding Oaktree Acquisition Corp Iii